Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 1,255,963 | reported | 04 Aug 2022 | tx 10+148,174−1,423,096 |
| MPM ACQUISITION CORP | 1,167,997 | reported | 08 Jan 2015 | tx 17+6,026,941−1,819,631 |
| Kalaris Therapeutics, Inc. | 18,000 | reported | 10 Apr 2025 | tx 36+26,692,145−23,096,271 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Apr 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 04 Aug 2022 | SALE | Cullinan Therapeutics, Inc. | 25,989 | 14.31 USD | |
| 03 Aug 2022 | SALE | Cullinan Therapeutics, Inc. | 19,129 | 14.24 USD | |
| 02 Aug 2022 | SALE | Cullinan Therapeutics, Inc. | 4,792 | 14.10 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 325,379 | 4.61 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 3,253,796 | 4.61 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 867,678 | 4.61 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 1,393,874 | 4.61 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 1,626,898 | 4.61 USD | |
| 28 Jul 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 684,622 | 4.61 USD | |
| 24 Jun 2022 | TAX_WITHHOLDING | Cullinan Therapeutics, Inc. | 45,078 | 13.39 USD | |
| 24 Jun 2022 | EXERCISE | Cullinan Therapeutics, Inc. | 104,845 | 4.30 USD | |
| 24 Jun 2022 | EXERCISE | Cullinan Therapeutics, Inc. | 35,529 | 4.30 USD | |
| 24 Jun 2022 | EXERCISE | Cullinan Therapeutics, Inc. | 35,529 | 0.00 USD | deriv |
| 24 Jun 2022 | EXERCISE | Cullinan Therapeutics, Inc. | 104,845 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 27,500 | 0.00 USD | deriv |
| 16 Sept 2021 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 7,800 | 0.00 USD | deriv |
| 11 Jan 2022 | OTHER | Cullinan Therapeutics, Inc. | 1,187,734 | — | |
| 10 Nov 2021 | SALE | Kalaris Therapeutics, Inc. | 680 | 24.77 USD | |
| 10 Nov 2021 | SALE | Kalaris Therapeutics, Inc. | 120 | 24.77 USD | |
| 09 Nov 2021 | SALE | Kalaris Therapeutics, Inc. | 572 | 24.79 USD | |
| 09 Nov 2021 | SALE | Kalaris Therapeutics, Inc. | 3,243 | 24.79 USD | |
| 05 Nov 2021 | SALE | Kalaris Therapeutics, Inc. | 1,257 | 24.80 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Aug 2020.